Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPYD intronic transcript 1 (DPYD-IT1) is a non-coding RNA arising from the intronic sequence of the DPYD gene (which encodes dihydropyrimidine dehydrogenase, an enzyme associated with pyrimidine metabolism and relevant pharmacogenetic adverse drug reactions). DPYD-IT1 does not encode a functional protein, is not implicated as a drug target, and its individual biological or clinical significance is currently undefined. No direct molecular function or disease association is reported for DPYD-IT1 specifically; all major clinical and therapeutic implications pertain to mutations in the protein-coding DPYD gene itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPYD intronic transcript 1 (DPYD-IT1).